References
Rolls B.J., Rolls E.T., Rowe E.A., Sweeney K. Sensory specific satiety in man. Physiol. Behav. 27: 137, 1981.
Rolls E.T. Feeding and reward. In: Hoebel B., Novin D. (Eds.), Neural Basis of Feeding and Reward. Haer Institute: Brunswick, ME, 1982, p. 323.
Nogren R., Grill H.J. Brain stem control of ingestive behavior. In: Pfaff W.D. (Ed.), Physiological Mechanisms of Motivation. Springer-Verlag, Berlin, 1982, p. 99.
Masdeu J.C., Ross E.R. Medullary satiety. Neurology 38: 1643, 1988.
Hyde T.M., Miselis R.R. Effects of area postrema/caudal medial nucleus of solitary tract lesions on food intake and body weight. Am. J. Physiol. 244: R577, 1983.
Morley J.E., Levine A.S., Murray S.S. Flavour modulates the antidipsogenic effect of substance P. Brain Res. 226: 334, 1981.
Levine A.S., Murray S.S., Kneip J., Grace M., Morley J.E. Flavor enhances the antidipsogenic effect of naloxone. Physiol. Behav. 28: 23, 1982.
Morley J.E. The neuroendocrine control of appetite: The role of the endogenous opiates, cholecystokinin, TRH, gamma-amino butyric acid and the diazepam receptor. Life Sci. 27: 355, 1980.
Smith G.P. Humoral mechanisms in the control of eating and body weight. In: Weiner H., Baum A. (Eds.), Perspectives in Behavioral Medicine: Eating Regulation and Discontrol. Lawrence Erlbaum Associates, Hillside, NJ, 1988, p. 59.
Sjodin L. Effects of secretin, cholecystokinin and caerulin on gastric secretion in response to sham feeding in dogs. Acta Physiol. Scand. 85:110; 1972.
Gibbs J., Young R.C., Smith G.P. Cholecystokinin decreases food intake in rats. J. Comp. Physiol. Psychol. 84: 488, 1973.
Morley J.E., Levine A.S., Bartness T.J., Nizielski S.E., Shaw M., Hughes J. Species differences in the response to cholecystokinin. Ann. NY Acad. Sci. 448: 413, 1985.
Kissileff H.R., Pi-Sunyer F.X., Thornton J., Smith G.P Cholecystokinin-octapeptide (CCK-8) decreases food intake in man. Am. J. Clin. Nutr. 34: 154, 1981.
Stacher G., Steinringer H., Schmierer G., Schneider C., Winklehner S. Cholecystokinin octapeptide decreases intake of solid food in man. Peptides 3:133, 1982.
Shaw M.J., Hughes J.J., Morley J.E., Levine A.S., Silvis S.E., Shafer R.B. Cholecystokinin octapeptide action on gastric emptying and food intake in normal and vagotomized man. Ann. New York Acad. Sci. 448: 640, 1985.
Moran T.H., McHugh P.R. Cholecystokinin suppresses food intake by inhibiting gastric emptying. Am. J. Physiol. 242: R491, 1982.
Smith G.P., Jerome C., Cushin B.J., Eterno R., Simansky K.J. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 213: 1036, 1981.
Morley J.E., Levine A.S., Kneip J., Grace M. The effect of vagotomy on the satiety effects of neuropeptides and naloxone. Life Sci. 30: 1943, 1982.
Smith G.P., Jerome C., Norgren R. Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats. Am. J. Physiol. 249: R638, 1985.
Crawley J.N., Schwaber J.S. Abolition of the behavioral effects of cholecystokinin following bilateral radiofrequency lesions of the parvocellular subdivision of the nucleus tractus solitarius. Brain Res. 295: 289, 1984.
Crawley J.N., Kiss J.Z., Mezey E. Bilateral midbrain transections block the behavior effects of cholecystokinin on feeding and exploration in rats. Brain Res. 322: 316, 1984.
Flood J.F., Smith G.E., Morley J.E. Modulation of memory processing by cholecystokinin: dependence on the vagus nerve. Science 236: 832, 1987.
Baile C.A., McLaughlin C.L., Della-Fera M.A. Role of cholecystokinin and opioid peptides in control of food intake. Physiol. Rev. 66:172, 1986.
Billington C.J., Levine A.S., Morley J.E. Are peptides truly satiety agents? A method of testing for neurohumoral satiety effects. Am. J. Physiol. 245: R920, 1983.
Smith G.P., Greenberg D., Falusco J.D., Gibbs J., Liddie R.A., Williams J.A. Plasma levels of cholecystokinin produced by satiating doses of exogenous CCK-8. Proc. Soc. Neurosci. Abstr. 11: 557, 1985.
Hanson H., Strouse J. Effects of the CCK antagonist, L-364, 718, on food intake and of the blockade of feeding produced by exogenous CCK in the rat (Abstract). Fed. Proc. 46:1480, 1987.
Hewson G., Leighton GE, Hill R.G., Hughes J. The cholecystokinin receptor antagonist, L364, 718, increases food intake in the rat by attenuation of the action of endogenous cholecystokinin. Br. J. Pharmacol. 93: 79, 1988.
Silver A.J., Flood J.F., Song A.M., Morley J.E. Evidence for a physiological role for cholecystokinin in the regulation of food intake in mice. Am. J. Physiol., in press, 1989.
Morley J.E., Flood J.F. An investigation of tolerance to the actions of 1eptogenic and anorexigenic drugs in mice. Life Sci, 41: 2157, 1987.
West D.B., Fey D., Woods S.C. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am. J.Physiol. 246: R776, 1984.
Morley J.E., Levine A.S. The role of the endogenous opiates as regulators of appetite. Am. J.Clin. Nutr. 35: 757, 1982.
Mitchell J.E., Laine D.E., Morley J.E., Levine A.S. Naloxone but not CCK-8 attenuates binge-eating in patients with the bulimia syndrome. Biol. Psychiatr. 21: 1399, 1986.
Geraciotti T.D., Liddle R.A. Impaired cholecystokinin secretion in bulimia nervosa. N. Eng. J. Med. 319: 683, 1988.
Morley J.E., Silver A.J. Anorexia in the elderly. Neurobiol. Aging 9: 9, 1988.
Silver A.J., Flood J.F., Morley J.E. Effect of gastrointestinal peptides on ingestion in young and old mice. Peptides 9: 221,1988.
Khalil T., Walker J.P., Wiener I., Fagan C.J., Townsend C.M., Greeley G.H., Thompson J.C. Effect of aging of gallbladder contraction and release of cholecystokinin-33 in humans. Surgery 98: 423, 1985.
Morley J.E. Neuropeptide regulation of appetite and weight. Endocr. Rev. 8:256, 1987.
Smith G.P. The peripheral control of appetite. Lancet 2: 88, 1983.
Gibbs J., Kulkosky P.J., Smith G.P. Effects of peripheral and central bombesin on feeding behavior of rats. Peptides 2 (Suppl. 2): 179, 1981.
Morley J.E., Levine A.S. Bombesin inhibits stress-induced eating. Pharmacol. Biochem. Behav. 14: 149, 1981.
Muurhainen N.E., Kissileff H.R., Thornton J., PiSunger F.X. Bombesin: Another peptide that inhibits feeding in man (abstract). Proc. Soc. Neurosci. 9:182, 1983.
Stein L.J., Woods S.C. Gastrin-releasing peptide reduces meal size in rats. Peptides 3: 833, 1982.
Morley J.E. Levine A.S., Kneip J., Grace M., Billington C.J. The effect of peripherally administered satiety substances on feeding induced by butorphanol tartrate. Pharmacol. Biochem. Behav. 19: 577, 1983.
Stuckey J.A., Gibbs J., Smith G.P. Neural disconnection of gut from brain blocks bombesin-induced satiety. Peptides 6:1249, 1985.
Hinton V., Rosofsky M., Granger J., Geary N, Combined injection potentiates the satiety effects of pancreatic glucagon, cholecystokinin and bombesin. Peptides 17: 615, 1986.
Geary N., Smith G.P. Selective hepatic vagotomy blocks pancreatic glucagon’s satiety effect. Physiol. Behav. 31: 391, 1983.
Penick S.B., Hinkle Jr. LE. Depression of food intake in healthy subjects by glucagon. N. Engl. J. Med. 264: 893, 1961.
Levine A.S., Morley J.E. Peripherally administered somatostatin reduces feeding by a vagal mediated mechanism. Pharmacol. Biochem. Behav. 16: 897, 1982.
Flood J.F., Morley J.E. Effects of bombesin and gastrin-releasing peptide on memory processing. Brain Res., 460: 314, 1988.
Morley J.E. Neuroendocrine effects of endogenous opioid peptides in human subjects: A review. Psychoneuroendocrinology 8: 361, 1983.
Morley J.E., Levine A.S., Yim G.K., Lowy M.T. Opioid modulation of appetite. Neurosci. Biobehav. Rev. 7: 281, 1983.
Billington C.J., Morley J.E., Levine A.S., Wright F., Seal U.S. Naloxone-induced suppression of feeding in tigers. Physiol. Behav. 34: 641,1985.
Morley J.E., Levine A.S., Plotka E.D., Seal U.S. The effect of naloxone on feeding and spontaneous locomotion in the wolf. Physiol. Behav. 30: 331, 1983.
Kavaliers M., Hirst M. Naloxone reversible stress-induced feeding and analgesia in the slug (Limax maximus). Life Sci. 38: 203, 1986.
Morley J.E., Levine A.S., Grace M., Kneip J. An investigation of the role of kappa opiate receptor agonists in the initiation of feeding. Life Sci. 31: 2617, 1982.
Morley J.E., Levine A.S. Dynorphin-(1–13) induces spontaneous feeding in rats. Life Sci. 29: 1901, 1981.
Morley J.E., Levine A.S. Involvement of dynorphin and the kappa opioid receptor in feeding. Peptides 4: 797, 1983.
Gosnell B.A., Morley J.E., Levine A.S. Opioid-induced feeding: localization of sensitive brain sites. Brain Res. 369:177, 1986.
Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Anatomy of CNS opioid receptors. TIPS 11:308, 1988.
Carr K.D., Bak T.H., Gioannini T.L., Simon E.J. Antibodies to dynorphin A (1–13) but not beta-endorphin inhibit electrically elicited feeding in the rat. Brain Res. 422 (2):384,1987.
Gosnell B.A. Involvement of u opioid receptors in the amygdala in the control of feeding. Neuropharmacology 27: 319, 1988.
Kavaliers M., Hirst M. Slugs and snails and opiate tales: opioids and feeding behavior in invertebrates. Fed. Proc. 46:168, 1987.
Rosmos D.R., Gosnell B.A., Morley J.E., Levine A.S. Effects of kappa opiate agonists, cholecystokinin and bombesin on intake of diets varying in carbohydrate to fat ratio in rats. J. Nutr. 117: 976, 1987.
Atkinson R.L. Opioid regulation of food intake and body weight in humans. Fed. Proc. 46:178, 1987.
Mitchell J.E., Morley J.E., Levine A.S., Hatsukami D., Gannon M., Pfohl D. High-dose naltrexone therapy and dietary counselling for obesity. Biol. Psychiatr. 22: 35, 1987.
Jonas J.M., Gold M.S. Naltrexone reverses bulimic symptoms. Lancet 1: 807, 1986.
Mitchell J., Jennings J., Christenson G., Huber M., Thomas B., Pomeroy C., Morley J.E. A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia. J. Clin. Psychopharmacol., in press, 1988.
Morley J.E., Parker S., Levine A.S. Effect of butorphanol tartrate on food and water consumption in humans. Am. J.Clin. Nutr. 42: 1175, 1985.
Facchinetti F., Giovannini C., Barletta C., Petraglia F., Buzzetti R., Burla F., Lazzari R., Genazzani A.R., Scavo D. Hyperendorphinemia in obesity and relationships to affective state. Physiol. Behav. 36: 937, 1986.
Panerai A.E., Cavagnini F., Invitti C., Lampertico M., Sacerdote P., Brambilla F. Plasma beta-endorphin and beta-lipotropin in anorexia nervosa. In: Ferrari E., Brambilla F. (Eds.), Disorders of Eating Behavior: A Psychoneuroendocrine Approach. Pergamon Press, Oxford, 1986, p. 219.
Kaye W.H., Pickar D., Naber D., Ebert M.H. Cerebrospinal fluid opioid activity in anorexia nervosa. Am. J. Psychiatr. 139: 643, 1982.
Kaye W.H., Berrettini W.H., Gwirtsman H.E., et al. Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin-related peptides (including beta-endorphin) in anorexia nervosa. Life Sci. 41:2147, 1987.
Gosnell B.A. Central structures involved in opioid-induced feeding. Fed. Proc. 46:163, 1987.
Morley J.E., Elson M.K., Levine A.S., Shafer R.B. The effects of stress on central nervous system concentrations of the opioid peptide, dynorphin. Peptides 3: 901, 1982.
Vaswani K.K., Tejwani G.A. Food deprivation-induced changes in the level of opioid peptides in the pituitary and brain of the rat. Life Sci. 38:197, 1986.
Morley J.E., Levine A.S. Stress-induced eating is mediated through endogenous opiates. Science 209:1259, 1980.
Morley J.E. Nutritional status of the elderly. Am. J. Med. 81: 679, 1986.
Gosnell B.A., Levine A.S., Morley J.E. The effects of aging on opioid modulation of feeding in rats. Life Sci. 32: 2793, 1983.
Morley J.E., Levine A.S. Corticotropin-releasing factor, grooming and ingestive behavior. Life Sci. 31: 1459, 1982.
Levine A.S., Rogers B., Kneip J., Grace M., Morley J.E. Effect of centrally administered corticotropin-releasing factor (CRF) on multiple feeding paradigms. Neuropharmacology 22: 337, 1983.
Krahn D.D., Gosnell B.A., Levine A.S., Morley J.E. Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res. 443: 63, 1988.
Krahn D.D., Gosnell B.A., Grace M., Levine A.S. CRF antagonist partially reverses CRF- and stressinduced effects on feeding. Brain Res. Bull. 17: 285, 1986.
Shibasaki T., Yamauchi N., Kato Y., Masuda A., Imaki T., Hotta M., Demura H., Oono H., Ling N., Shizume K. Involvement of corticotropin-releasing factor in restraint stress-induced anorexia and reversion of the anorexia by somatostatin in the rat. Life Sci. 43: 1103, 1988.
Buckingham J.C., Hodges J.R. Hypothalamic receptors influencing the secretion of corticotropin releasing hormone in the rat. J. Physiol. 290: 421, 1979.
Al-Damluji S. Adrenergic mechanisms in the control of corticotropin secretion. J. Endocrinol. 119: 5, 1988.
Ganong W.F. Neurotransmitters and pituitary function: regulation of ACTH secretion. Fed. Proc. 39:2923, 1980.
Calogero A.E., Gallucci W.T., Chrousos G.P., Gold P.W. Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro. J.Clin. Invest. 82: 839, 1988.
Ganong W.F., Kramer N., Salmon J., Reid I.A., Lovinger R., Scapagnini U., Boryczka A.T., Shackelford R. Pharmacological evidence for inhibition of ACTH secretion by a central adrenergic system in the dog. Neuroscience 1:167, 1976.
Leibowitz S.F. Brain monoamines and peptides: role in the control of eating behavior. Fed. Proc. 45:1396, 1986.
Tsagarakis S., Holly J.M.P., Rees L.H., Besser G.M., Grossman A. Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro. Endocrinology 123:1962, 1988.
Morley J.E., Levine A.S., Gosnell B.A. Kneip J., Grace M. Effect of neuropeptide Y on ingestive behaviors in the rat. Am. J. Physiol. 252: R599, 1987.
Beaumont P.J.V. The endocrinology of anorexia nervosa. Med. J. Aust. 2:225, 1983.
Hotta M., Shibasaki T., Masuda A., Imaki T., Demura H., Ling N., Shizume M. The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients. J. Clin. Endocrinol. Metab. 62: 319, 1986.
Kaye W.H., Gwirtsman H.E., George D.T., Ebert M.H., Jimerson D.C., Tomai T.P., Chrousos G.P., Gold P.W. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function and intensity of depression. J. Clin. Endocrinol. Metab. 64: 203, 1987.
Arase K., York D.A., Shimizu H., Shargill N., Bray G.A. Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats. Am. J. Physiol. 225: E255,1989.
Tache Y., Maeda-Hagiwara M., Turkelson C.M. Central nervous system action of corticotropin-releasing factor to inhibit gastric emptying in rats. Am. J. Physiol. 253: G241, 1987.
Rivier C., Rivier J., Vale W. Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Science 231: 607, 1986.
Gray T.S., Morley J.E. Neuropeptide Y: Anatomical distribution and possible function in mammalian nervous system. Life Sci. 38: 389, 1986.
Clark J.J., Kalra P.S., Crawley W.R., Kalra S.P. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115: 427,1984.
Stanley B.G., Leibowitz S.F. Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci. 33: 26t35, 1984.
Levine A.S., Morley J.E. Neuropeptide Y: A potent inducer of consummatory behavior in rats. Peptides 5:1025, 1984.
Steinman J.L., Gunion M.W., Morley J.E. Third and fourth ventricle neuropeptide Y stimulates feeding and drinking in rats. Fed. Proc. 46: 1125, 1987.
Sahu A., Kalra P.S., Kalra S.P. Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides 9: 83, 1988.
Morley J.E. Neuropeptide Y: A new stress hormone? In: Florin I., Weiner H., Hellhammer D. (Eds.), Neuronal Control of Bodily Function — Basic and Clinical Aspects. IV. New Frontiers of Stress Research, 1988, in press.
Stanley B.G., Kyrkouli S.E., Lampert S., Leibowitz S.F. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 7:1189, 1986.
Morley J.E., Levine A.S., Grace M., Kneip J. Peptide YY (PYY) - a potent orexigenic agent. Brain Res. 341: 200, 1985.
Kyrkouli S.E., Stanley B.G., Leibowitz S.F. Galanin: stimulation of feeding induced by medial hypothalamic injection of this novel peptide. Eur. J. Pharmacol. 122:159, 1986.
Tempel D.L., Leibowitz K.J., Leibowitz S.F. Effects of PVN galanin on macronutrient selection. Peptides 9: 309, 1988.
Vaccarino F.J., Bloom F.E., Rivier J., Vale W., Koob G.F. Stimulation of food intake in rats by centrally administered hypothalamic growth hormone-releasing factor. Nature 314:167, 1985.
Maki T., Shibasaki T., Hotta M., Masuda A., Demura H., Shizume K., Ling N. The satiety effect of growth hormone-releasing factor in rats. Brain Res. 340:186, 1985.
Morley J.E., Levine A.S., Grace M., Kneip J. Dynorphin-(1–13), dopamine and feeding in rats. Pharmacol. Biochem. Behav. 16: 701, 1982.
Morley J.E., Levine A.S. Thyrotropin-releasing hormone (TRH) suppresses stress-induced eating. Life Sci. 27:269, 1980.
Morley J.E. Levine A.S., Prasad C. Histidyl-proline diketopiperazine decreases food intake in rats. Brain Res. 210: 475, 1981.
Wilber J.F., Rogers D., Iriuchijima T., Prasad C. Histidyl-proline diketopiperazine (cyclo His-Pro): a potent and chronic appetite-inhibiting neuropeptide. Clin. Res. 34: 727A, 1986.
Mori M., Pegues J., Prasad C., Wilber J.F. Fasting and feeding associated changes in cyclo (His-Pro)-like immunoreactivity in the rat brain. Brain Res. 268:181, 1983.
Freed W.J., Perlow M.J., Wyatt R.D. Calcitonin: inhibitory effect on eating in rats. Science 206: 850, 1979.
Krahn D.D., Gosnell B.A., Levine A.S., Morley J.E. Effects of calcitonin gene-related peptide on food intake. Peptide 5: 861, 1984.
Levine A.S., Morley J.E. Reduction of feeding in rats by calcitonin. Brain Res. 222:187, 1981.
deBeaurepaire R., Freed W.J. Anatomical mapping of the rat hypothalamus for calcitonin-induced anorexia. Pharmacol. Biochem. Behav. 27:177, 1987.
deBeaurepaire R., Saudeau C. Anorectic effect of calcitonin, neurotensin and bombesin infused in the area of the rostral part of the nucleus of the tractus solitarius in the rat. Peptides 9: 729, 1988.
Morley J.E., Levine A.S. The central control of appetite. Lancet 1: 398, 1983.
Faris P.L., Scallett A.C., Olney J.W., Della-Fera M.A., Baile C.A. Behavioral and immunohistochemical analysis of cholecystokinin in the hypothalamic paraventricular nucleus. Proc. Soc. Neurosci. Abstr. 10: 652, 1984.
Stuckey J.A., Gibbs J. Lateral hypothalamic injection of bombesin decreases food intake in rats. Brain Res. Bull. 8:617, 1982.
Landheim E.E., Ritter R.C. Suppression of food intake by low-dose infusion of bombesin into the fourth ventricle. Proc. Soc. Neurosci. 11: 343, 1985.
Morley J.E., Kay N.E., Solomon G.F., Plotnikoff N.P. Neuropeptides: conductors of the immune orchestra. Life Sci. 41: 527, 1987.
Plata-Salaman C.R. Oomura Y., Kay Y. Tumor necrosis factor and interleukin 1B: suppression of food intake by direct action in the central nervous system. Brain Res. 448:106, 1988.
Knoll J. Satietin: a 50,000 dalton glycoprotein in human serum with potent, long-lasting and selective anorectic activity. J. Neural. Transm. 59:163, 1984.
Bellinger L.L., Mendel V.E. The effect of intracerebroventricularly infused satietin on conditioned taste aversion and feeding in rats fasted different lengths. Pharmacol. Biochem. Behav. 23: 559, 1985.
Knoll J. Satietin: a blood-borne glycoprotein in the regulation of food intake. In: Lal H., Labella F., Lane J. (Eds.), Endocoids. Allan R. Liss, New York, 1985, p. 515. Physiol. Behav. 27: 137, 1981.
Levine A.S., Morley J.E., Brown D.M., Handwerger B.S. Extreme sensitivity of diabetic mice to naloxone-induced suppression of food intake. Physiol. Behav. 28: 987, 1982.
Levine A.S., Morley J.E., Kneip J., Grace M., Brown D.M. Environment modulates naloxone’s suppressive effect on feeding in diabetic and non-diabetic rats. Physiol. Behav. 34: 391, 1988.
Morley G.K., Mooradian A.D., Levine A.S., Morley J.E. Why is diabetic peripheral neuropathy painful? The effect of glucose on pain perception in humans. Am. J. Med. 77: 79, 1984.
Simon G.S., Dewey W.L. Narcotics and diabetes. I. The effects of streptozoto-cin-induced diabetes on the antinociceptive potency of morphine. J. Pharmacol. Exp. Ther. 237: 848, 1986.
Brase D.A., Dewey W.L. Glucose and morphine-induced analgesia. In: Morley J.E., Sterman B., Walsh J.H. (Eds.), Nutritional Modulation of Neural Function. Academic Press, San Diego, 1988, p. 263.
Shook J.E., Kachur J.F., Brase D.A., Dewey W.L. Morphine dependence and-diabetes. II. Alterations of normorphine potency in the guinea pig ileum and mouse vas deferens and of ileal morphine dependence by changes in glucose concentration. J. Pharmacol. Exp. Ther. 237: 848, 1986.
Morley J.E., Levine A.S., Hess S.A., Brown D.B., Handwerger B.S. Evidence for in vivo and in vitro modulation of the opiate receptor by glucose. Proc. Soc. Neurosci. 7: 854, 1981.
Edens N.K., Friedman M.I. Satiating effect of fat in diabetic rats: gastrointestinal and post absorptive factors. Am. J. Physiol. 255: R123, 1988.
Morley J.E., Hernandez E.N., Flood J.F. Neuropeptide Y increases food intake in mice. Ann. J. Physiol. 253: R516, 1987.
Williams G., Steel J.H., Gaveloso H., Ghatie M.A., Lee Y.C., Gell J.S., Burrin J.M., Polak J.M., Bloom S.R. Increased hypothalamic neuropeptide Y concentrations in diabetic rat. Diabetes 37: 763, 1988.
Chu P.C., Lin M.T., Shian L.R., Leu S.Y. Alterations in physiologic functions and in brain monoamine content in streptozotocin-diabetic rats. Diabetes 35:481, 1986.
Barbour O. Observations on the use of insulin in non-diabetic children. III. Med. J. 45:131, 1924.
Novin D. Gustatory and visceral modulation of feeding. In: Morley J.E., Sterman M.B., Walsh J.H. (Eds.), Nutritional Modulation of Neural Function. Academic Press, San Diego, 1988, p. 67.
Triscari J., Sullivan A.C. A pharmacotherapeutic approach to the regulation of hyperinsulinemia and obesity. Int. J. Obesity 3: 43, 1987.
Woods S.C., Porte D. Jr. The role of insulin as a satiety factor in the central nervous system. In: Szabo A.J. (Ed.), Advances in Metabolic Disorders, CNS Regulation of Carbohydrate Metabolism. Academic Press, New York, 1983, vol. 10, p. 457.
Van der Weele D.A., Pi-Sunyer F.X., Novin D., Bush M.J. Chronic insulin infusion suppresses food ingestion and body weight gain in rats. Brain Res. Bull. 5:7, 1980.
Woods S.C., Lotter E.C., McKay L.D., Porte D. Jr. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282: 503, 1979.
Strubbe J.H., Mein C.G. Increased feeding in response to bilateral injections of insulin antibodies into the VMH. Physiol. Behav. 19: 309, 1977.
Tannebaum G.S., Gyda H.I., Posner B.I. Insulin-like growth factors: a role in growth hormone negative feedback and body weight regulation. Science 220: 777, 1983.
Bartness T.J., Billington C.J., Levine A.S., Morley J.E., Rowland N.E., Brown D.M. Insulin and metabolic efficiency in rats. II. Effects of NE and cold exposure. Am. J. Physiol. 251: R1118,1986.
Martin W.R., Wilker A., Eades C.G., Pescor F.T. Tolerance to and physical dependence on morphine in rats. Psychopharmacologica 4: 247, 1963.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morley, J.E. Appetite regulation: The role of peptides and hormones. J Endocrinol Invest 12, 135–147 (1989). https://doi.org/10.1007/BF03349944
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349944